טוען...
A mitochondrial based oncology platform for targeting cancer stem cells (CSCs): MITO-ONC-RX
Here, we wish to propose a new systematic approach to cancer therapy, based on the targeting of mitochondrial metabolism, especially in cancer stem cells (CSCs). In the future, we envision that anti-mitochondrial therapy would ultimately be practiced as an add-on to more conventional therapy, largel...
שמור ב:
| הוצא לאור ב: | Cell Cycle |
|---|---|
| Main Authors: | , , , , , |
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
Taylor & Francis
2018
|
| נושאים: | |
| גישה מקוונת: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6226227/ https://ncbi.nlm.nih.gov/pubmed/30257595 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/15384101.2018.1515551 |
| תגים: |
הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|